Soleus Capital Management, L.P.
CIK 1802630 · View on SEC EDGAR ↗
- Portfolio value
- $2.9B
- Positions
- 97
- As of
- June 30, 2026
#1,196 of 9,443 by 13F value · top 12.7%
Portfolio value QoQ: +17.5% 13F does not disclose cash
- Top 10 holdings weight
- 48.91%
- Top 25 holdings weight
- 72.19%
- Positions above 1%
- 29
- Effective number of positions
- 27.0
Based on 13F long-equity holdings only (cash, bonds, shorts not disclosed)
Turnover Q2 2026: 28.95% Est. buys $777,526,622 · sells $927,740,678
Median holding: 3.0 quarters Tracked Q4 2024–Q2 2026 · 49.2% still held
- New positions
- 22
- Increased
- 25
- Decreased
- 41
- Closed
- 18
On this page
- Performance vs S&P How this manager's 13F portfolio performed against the S&P 500.
- Sector breakdown How the portfolio splits across market sectors.
- Portfolio Every stock this institution reports holding, from its latest 13F.
- High-conviction bets The holdings this manager is most concentrated in.
- Biggest new bets Brand-new positions opened in the latest quarter.
- Top moves The biggest position increases and decreases this quarter.
- Exited positions Positions the manager fully sold out of last quarter.
Performance vs S&P 500
Annualized: +64.2% · S&P 500: +18.0%
Approximates a buy-and-hold portfolio built from quarterly SEC 13F snapshots. Excludes cash, short positions, options/derivatives, and non-13(f) securities — reflects the disclosed long-equity book only, not total fund AUM. SEC filing lag is up to 45 days; this is not a real-time-copyable timing.
Priceable coverage: 99.3% · Options excluded: 7.8%
Sector breakdown
Healthcare
97.8%
Other/Unmapped
2.2%
Full portfolio 97 positions
| Type | Streak | 8Q trend | |||||
|---|---|---|---|---|---|---|---|
| KRYS Krystal Biotech, Inc. - Common Stock | $349,092,534 | 12.03% | 939,254 | $51,227,100 | Down ×1 | ||
| CELC Celcuity Inc. - Common Stock | $178,305,749 | 6.14% | 1,704,318 | $31,706,844 | Up ×1 | ||
| TGTX TG Therapeutics, Inc. - Common Stock | $160,858,551 | 5.54% | 2,927,895 | $27,004,574 | Down ×1 | ||
| PODD Insulet Corporation - Common Stock | $159,710,250 | 5.50% | 1,049,000 | $41,675,250 | Up ×2 | ||
| NVCR NovoCure Limited - Ordinary Shares | $150,188,025 | 5.18% | 9,913,401 | $35,820,963 | Down ×1 | ||
| UTHR United Therapeutics Corporation - Common Stock | $122,229,804 | 4.21% | 225,587 | $11,231,657 | Up ×2 | ||
| INSP Inspire Medical Systems, Inc. Common Stock | $86,161,360 | 2.97% | 1,931,436 | $56,435,858 | Up ×2 | ||
| RIGL Rigel Pharmaceuticals, Inc. - Common Stock | $72,117,876 | 2.49% | 1,843,504 | $71,847,476 | Up ×1 | ||
| ANIP ANI Pharmaceuticals, Inc. - Common Stock | $71,833,173 | 2.48% | 867,760 | $8,756,486 | Up ×4 | ||
| BBNX Beta Bionics, Inc. - Common Stock | $68,849,498 | 2.37% | 4,393,714 | $25,217,398 | Up ×2 | ||
| VCEL Vericel Corporation - Common Stock | $64,917,672 | 2.24% | 1,459,152 | $-17,086,199 | Down ×1 | ||
| PRAX Praxis Precision Medicines, Inc. - Common Stock | $59,430,916 | 2.05% | 177,517 | $-47,058,356 | Down ×5 | ||
| GERN Geron Corporation - Common Stock | $54,795,084 | 1.89% | 42,808,659 | $-7,052,818 | Up ×5 | ||
| ALKS Alkermes plc - Ordinary Shares | $53,927,659 | 1.86% | 1,029,252 | $-15,762,092 | Down ×1 | ||
| ERAS Erasca, Inc. - Common Stock | $49,464,000 | 1.70% | 2,700,000 | ||||
| NPCE Neuropace, Inc. - Common Stock | $46,257,729 | 1.59% | 2,911,122 | $7,699,207 | Down ×1 | ||
| PGNY Progyny, Inc. - Common Stock | $46,185,660 | 1.59% | 1,602,000 | $11,088,000 | Down ×1 | ||
| INDV Indivior Pharmaceuticals, Inc. - Common Stock | $43,655,920 | 1.50% | 1,064,000 | $4,824,400 | Down ×1 | ||
| Unknown issuer (CUSIP: 698955101) | $40,098,966 | 1.38% | 1,465,070 | Up ×1 | |||
| EDAP EDAP TMS S.A. - American Depositary Shares, each representing One Ordinary Share | $37,861,936 | 1.30% | 7,309,254 | $10,671,511 | |||
| GMED Globus Medical, Inc. Class A Common Stock | $37,049,527 | 1.28% | 468,922 | $-25,801,350 | Down ×2 | ||
| RCUS Arcus Biosciences, Inc. Common Stock | $36,032,193 | 1.24% | 1,168,738 | $26,269,360 | Up ×1 | ||
| SNDX Syndax Pharmaceuticals, Inc. - Common Stock | $35,588,933 | 1.23% | 1,628,039 | $-4,751,638 | Down ×2 | ||
| NRIX Nurix Therapeutics, Inc. - Common stock | $35,544,854 | 1.22% | 1,465,163 | $21,003,327 | Up ×1 | ||
| LEGN Legend Biotech Corporation - American Depositary Shares | $34,800,400 | 1.20% | 1,205,000 | Up ×1 | |||
| JBIO Jade Biosciences, Inc. - Common Stock | $34,456,332 | 1.19% | 1,550,690 | $23,262,079 | Up ×1 | ||
| UNH UnitedHealth Group Incorporated Common Stock (DE) | $33,250,400 | 1.15% | 80,000 | ||||
| AVTX Avalo Therapeutics, Inc. - Common Stock | $30,583,993 | 1.05% | 1,654,978 | $23,985,261 | Up ×1 | ||
| URGN UroGen Pharma Ltd. - Ordinary Shares | $30,537,008 | 1.05% | 829,810 | $17,465,548 | Up ×2 | ||
| MBX MBX Biosciences, Inc. - Common Stock | $28,443,401 | 0.98% | 515,279 | $23,103,326 | Up ×1 | ||
| PALI Palisade Bio, Inc. - Common Stock | $27,303,106 | 0.94% | 13,063,687 | Up ×1 | |||
| PHVS Pharvaris N.V. - Ordinary Shares | $25,274,764 | 0.87% | 730,907 | $5,441,795 | Up ×1 | ||
| ORGO Organogenesis Holdings Inc. - Class A | $24,642,511 | 0.85% | 10,140,951 | $738,807 | Up ×2 | ||
| SUPN Supernus Pharmaceuticals, Inc. - Common Stock | $24,185,200 | 0.83% | 520,000 | Up ×1 | |||
| PRCT PROCEPT BioRobotics Corporation - Common Stock | $22,647,740 | 0.78% | 1,003,000 | $18,646,140 | Up ×1 | ||
| TNGX Tango Therapeutics, Inc. - Common Stock | $22,163,340 | 0.76% | 709,000 | $12,749,340 | Up ×2 | ||
| IKT Inhibikase Therapeutics, Inc. - Common Stock | $22,076,250 | 0.76% | 10,875,000 | $3,806,250 | |||
| TRVI Trevi Therapeutics, Inc. - Common Stock | $21,999,876 | 0.76% | 1,179,618 | $2,673,276 | Down ×1 | ||
| BMRN BioMarin Pharmaceutical Inc. - Common Stock | $21,490,230 | 0.74% | 375,572 | $-15,260,582 | Down ×2 | ||
| LIVN LivaNova PLC - Ordinary Shares | $20,965,114 | 0.72% | 254,957 | $-16,058,586 | Down ×1 | ||
| ARGX argenx SE - American Depositary Shares | $18,513,650 | 0.64% | 19,955 | $15,957,775 | Up ×1 | ||
| NVCT Nuvectis Pharma, Inc. - Common Stock | $18,390,000 | 0.63% | 1,000,000 | Up ×1 | |||
| CAPR Capricor Therapeutics, Inc. - Common Stock | $18,342,627 | 0.63% | 761,737 | ||||
| EWTX Edgewise Therapeutics, Inc. - Common Stock | $18,319,620 | 0.63% | 450,889 | $-27,352,703 | Down ×1 | ||
| PRLD Prelude Therapeutics Incorporated - Common Stock | $18,006,755 | 0.62% | 3,378,378 | Up ×1 | |||
| XENE Xenon Pharmaceuticals Inc. - Common Shares | $16,116,120 | 0.56% | 267,000 | $-863,680 | Down ×1 | ||
| CCCC C4 Therapeutics, Inc. - Common Stock | $15,775,171 | 0.54% | 3,377,981 | $5,770,804 | Down ×1 | ||
| KNSA Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares | $15,754,274 | 0.54% | 246,353 | $-9,348,873 | Down ×2 | ||
| KIDS OrthoPediatrics Corp. - Common Stock | $14,005,915 | 0.48% | 732,144 | $4,238,771 | Up ×4 | ||
| Unknown issuer (CUSIP: 05348Y105) | $13,793,480 | 0.48% | 419,000 | Up ×1 | |||
| BDSX Biodesix, Inc. - Common Stock | $13,213,353 | 0.46% | 585,958 | $7,172,667 | Up ×1 | ||
| SYRE Spyre Therapeutics, Inc. - Common Stock | $13,050,660 | 0.45% | 147,000 | Up ×1 | |||
| TWST Twist Bioscience Corporation - Common Stock | $10,764,232 | 0.37% | 104,629 | $-47,525,178 | Down ×3 | ||
| VIR Vir Biotechnology, Inc. - Common Stock | $10,190,000 | 0.35% | 1,000,000 | $-7,747,920 | Down ×1 | ||
| ALNY Alnylam Pharmaceuticals, Inc. - Common Stock | $9,949,042 | 0.34% | 33,050 | $-33,609,994 | Down ×1 | ||
| IMVT Immunovant, Inc. - Common Stock | $9,709,560 | 0.33% | 252,000 | $3,996,360 | Up ×1 | ||
| INSM Insmed Incorporated - Common Stock | $9,622,455 | 0.33% | 90,250 | $7,946,375 | Up ×1 | ||
| SEPN Septerna, Inc. - Common Stock | $9,209,750 | 0.32% | 275,000 | $2,601,500 | |||
| SOPH SOPHiA GENETICS SA - Ordinary Shares | $9,030,050 | 0.31% | 1,565,000 | $-127,450 | Down ×1 | ||
| NKTR Nektar Therapeutics - Common Stock | $8,960,951 | 0.31% | 128,362 | Up ×1 | |||
| MIRM Mirum Pharmaceuticals, Inc. - common stock | $8,780,250 | 0.30% | 75,000 | $-28,200,018 | Down ×2 | ||
| AORT Artivion, Inc. Common Stock | $8,718,360 | 0.30% | 388,000 | Up ×1 | |||
| TNDM Tandem Diabetes Care, Inc. - Common Stock | $8,676,750 | 0.30% | 575,000 | $-6,333,360 | Down ×1 | ||
| ELVN Enliven Therapeutics, Inc. - Common Stock | $8,408,108 | 0.29% | 165,677 | $-641,957 | Down ×2 | ||
| SION Sionna Therapeutics, Inc. - Common Stock | $7,816,451 | 0.27% | 177,687 | $-3,949,964 | Down ×1 | ||
| BLTE Belite Bio, Inc - American Depositary Shares | $7,779,938 | 0.27% | 50,524 | ||||
| CERS Cerus Corporation - Common Stock | $7,300,000 | 0.25% | 2,500,000 | $-12,271,734 | Down ×1 | ||
| SLN Silence Therapeutics Plc - American Depository Share | $6,917,400 | 0.24% | 630,000 | Up ×1 | |||
| Unknown issuer (CUSIP: 4525EP200) | $6,916,500 | 0.24% | 450,000 | Up ×1 | |||
| IVVD Invivyd, Inc. - Common Stock | $6,725,093 | 0.23% | 7,708,727 | $-3,296,252 | |||
| MRK Merck & Company, Inc. Common Stock (new) | $6,425,000 | 0.22% | 50,000 | $-17,993,870 | Down ×1 | ||
| RLMD Relmada Therapeutics, Inc. - Common Stock | $5,827,374 | 0.20% | 842,106 | $-33,684 | |||
| GPCR Structure Therapeutics Inc. - American Depositary Shares | $5,742,690 | 0.20% | 107,000 | $1,886,690 | Up ×1 | ||
| EOLS Evolus, Inc. - Common Stock | $5,707,650 | 0.20% | 822,428 | $-3,520,780 | Down ×1 | ||
| ANL Adlai Nortye Ltd. - American Depositary Shares | $4,663,515 | 0.16% | 405,523 | Up ×1 | |||
| ZNTL Zentalis Pharmaceuticals, Inc. - common stock | $4,607,500 | 0.16% | 950,000 | Up ×1 | |||
| KPTI Karyopharm Therapeutics Inc. - Common Stock | $4,298,800 | 0.15% | 440,000 | $1,848,000 | |||
| CNTX Context Therapeutics Inc. - Common Stock | $3,912,274 | 0.13% | 7,063,141 | $-14,331,155 | Up ×1 | ||
| LUNG Pulmonx Corporation - Common Stock | $3,624,820 | 0.12% | 2,788,323 | $27,883 | |||
| SABS SAB Biotherapeutics, Inc. - Common Stock | $3,510,000 | 0.12% | 900,000 | $-511,500 | Down ×1 | ||
| TECX Tectonic Therapeutic, Inc. - Common Stock | $3,495,388 | 0.12% | 101,684 | $-265,864 | Down ×1 | ||
| AXGN Axogen, Inc. - Common Stock | $2,634,493 | 0.09% | 57,036 | $-19,866,409 | Down ×3 | ||
| MSLE Satellos Bioscience Inc. - Common Stock | $2,444,141 | 0.08% | 314,359 | $111,300 | Down ×1 | ||
| AVBP ArriVent BioPharma, Inc. - Common Stock | $1,737,000 | 0.06% | 50,000 | Up ×1 | |||
| CORT Corcept Therapeutics Incorporated - Common Stock | $1,708,828 | 0.06% | 19,653 | $-9,800,927 | Down ×1 | ||
| SLDB Solid Biosciences Inc. - Common Stock | $1,498,500 | 0.05% | 150,000 | Up ×1 | |||
| VCYT Veracyte, Inc. - Common Stock | $1,468,250 | 0.05% | 25,000 | $-8,836,116 | Down ×1 | ||
| CGEM Cullinan Therapeutics, Inc. - Common Stock | $910,500 | 0.03% | 50,000 | $-4,918,442 | Down ×1 | ||
| NSPR InspireMD Inc. - Common Stock | $732,100 | 0.03% | 1,045,708 | $-972,404 | |||
| WGS GeneDx Holdings Corp. - Class A Common Stock | $686,500 | 0.02% | 10,000 | ||||
| IOVA Iovance Biotherapeutics, Inc. - Common Stock | $624,000 | 0.02% | 150,000 | $-2,886,000 | Down ×1 | ||
| LRMR Larimar Therapeutics, Inc. - Common Stock | $573,711 | 0.02% | 188,102 | $-4,227,609 | Down ×1 | ||
| CGON CG Oncology, Inc. - Common stock | $355,250 | 0.01% | 5,000 | $-998,350 | Down ×3 | ||
| QNRX Quoin Pharmaceuticals, Ltd. - American Depositary Shares | $352,013 | 0.01% | 72,730 | $-128,005 | |||
| EQ Equillium, Inc. - Common Stock | $288,000 | 0.01% | 90,000 | Up ×1 | |||
| NTRA Natera, Inc. - Common Stock | $271,450 | 0.01% | 1,000 | $-23,527,360 | Down ×1 | ||
| NEO NeoGenomics, Inc. - Common Stock | $145,900 | 0.01% | 10,000 | $-1,152,600 | Down ×2 | ||
| No matches | |||||||
Conviction holdings
Positions increased for 3+ consecutive quarters.
Share counts are as reported in 13F filings (not split-adjusted)
Biggest new bets
New positions opened this quarter, largest first.
| Security | Value | Shares | % of portfolio |
|---|---|---|---|
| ERAS | $49,464,000 | 2,700,000 | 1.70% |
| Unknown issuer (CUSIP: 698955101) | $40,098,966 | 1,465,070 | 1.38% |
| LEGN | $34,800,400 | 1,205,000 | 1.20% |
| UNH | $33,250,400 | 80,000 | 1.15% |
| PALI | $27,303,106 | 13,063,687 | 0.94% |
| SUPN | $24,185,200 | 520,000 | 0.83% |
| NVCT | $18,390,000 | 1,000,000 | 0.63% |
| CAPR | $18,342,627 | 761,737 | 0.63% |
| PRLD | $18,006,755 | 3,378,378 | 0.62% |
| Unknown issuer (CUSIP: 05348Y105) | $13,793,480 | 419,000 | 0.48% |
| SYRE | $13,050,660 | 147,000 | 0.45% |
| NKTR | $8,960,951 | 128,362 | 0.31% |
| AORT | $8,718,360 | 388,000 | 0.30% |
| BLTE | $7,779,938 | 50,524 | 0.27% |
| SLN | $6,917,400 | 630,000 | 0.24% |
Top movers (QoQ)
| Security | Action | Shares Δ | Value Δ |
|---|---|---|---|
| INSP | Bought more | +1.4M | +$56.4M |
| KRYS | Trimmed | -214K | +$51.2M |
| PRAX | Trimmed | -153K | -$47.1M |
| PODD | Bought more | +486K | +$41.7M |
| NVCR | Trimmed | -579K | +$35.8M |
| ALNY | Trimmed | -99K | -$33.6M |
| CELC | Bought more | +420K | +$31.7M |
| MIRM | Trimmed | -325K | -$28.2M |
| EWTX | Trimmed | -999K | -$27.4M |
| TGTX | Trimmed | -1.1M | +$27.0M |
2 positions hidden (data completeness check)
Exited positions
Includes corporate events (mergers, delistings) — not all exits are sells
Closed positions reflect 13F reporting changes; for index managers these are often mechanical (delisting, M&A, index rebalancing), not active decisions.
| Security | Quarter | Shares before | Value before | Price since exit |
|---|---|---|---|---|
| XBI | March 31, 2026 | 2,900,000 | $353,597,000 | No longer tracked |
| ELV | Dec. 31, 2025 | 259,650 | $83,898,108 | 14.0% |
| FOLD | March 31, 2026 | 5,207,284 | $74,151,724 | No longer tracked |
| GSK | March 31, 2026 | 639,000 | $31,336,560 | -6.3% |
| UNH | Sept. 30, 2025 | 86,250 | $26,907,413 | 12.2% |
| AZN | March 31, 2025 | 409,000 | $26,797,680 | 125.2% |
| RAPT | March 31, 2026 | 764,000 | $25,876,680 | No longer tracked |
| NBIX | March 31, 2026 | 175,982 | $24,959,527 | 16.9% |
| GRFS | Dec. 31, 2025 | 2,500,000 | $24,900,000 | -13.6% |
| QDEL | March 31, 2025 | 547,082 | $24,372,503 | -58.8% |
| SRDX | Sept. 30, 2025 | 789,060 | $23,442,973 | No longer tracked |
| TFX | March 31, 2026 | 190,000 | $23,187,600 | 12.8% |
| PCVX | June 30, 2026 | 385,472 | $22,399,778 | 7.2% |
| ICLR | June 30, 2026 | 192,000 | $21,246,720 | -0.6% |
| IART | Dec. 31, 2025 | 1,440,818 | $20,646,922 | 32.9% |
| HUM | Sept. 30, 2025 | 79,600 | $19,460,608 | 47.6% |
| CAPR | March 31, 2026 | 646,390 | $18,654,815 | -77.2% |
| HOLX | June 30, 2025 | 302,000 | $18,654,540 | No longer tracked |
| THC | March 31, 2026 | 92,500 | $18,381,600 | 45.5% |
| ALNY | March 31, 2025 | 76,800 | $18,071,808 | -14.9% |
| TVTX | June 30, 2026 | 546,000 | $16,221,660 | 14.4% |
| TAK | March 31, 2025 | 1,180,000 | $15,623,200 | 21.9% |
| ASND | Sept. 30, 2025 | 85,000 | $14,671,000 | 29.7% |
| SNY | June 30, 2025 | 226,218 | $12,546,050 | -5.5% |
| QURE | Dec. 31, 2025 | 200,000 | $11,674,000 | 106.6% |
| THTX | Sept. 30, 2025 | 4,801,376 | $11,331,247 | No longer tracked |
| ADMA | Dec. 31, 2025 | 738,000 | $10,819,080 | -46.2% |
| ENOV | Sept. 30, 2025 | 315,000 | $9,878,400 | -13.6% |
| LLY | March 31, 2025 | 11,658 | $8,999,976 | 51.3% |
| INBX | June 30, 2026 | 131,000 | $8,807,130 | 6.1% |
| DXCM | June 30, 2026 | 140,000 | $8,792,000 | 32.8% |
| TERN | March 31, 2026 | 212,710 | $8,593,484 | No longer tracked |
| CDTX | March 31, 2026 | 38,811 | $8,572,962 | No longer tracked |
| VSTM | Dec. 31, 2025 | 935,909 | $8,264,076 | -10.0% |
| PTGX | June 30, 2025 | 169,000 | $8,172,840 | 174.7% |
| PCVX | March 31, 2025 | 99,050 | $8,108,233 | 65.0% |
| ERAS | March 31, 2026 | 2,162,162 | $8,043,243 | 9.0% |
| NUVL | Dec. 31, 2025 | 88,000 | $7,610,240 | No longer tracked |
| TEVA | June 30, 2025 | 450,500 | $6,924,185 | 121.8% |
| CSTL | March 31, 2025 | 252,917 | $6,740,238 | 62.4% |
| BLTE | March 31, 2026 | 40,354 | $6,455,026 | 2.9% |
| ABVX | March 31, 2026 | 45,000 | $6,068,475 | 7.3% |
| ESTA | Dec. 31, 2025 | 139,512 | $5,718,597 | -2.0% |
| MLTX | March 31, 2026 | 400,000 | $5,272,000 | -14.9% |
| IMUX | June 30, 2026 | 4,500,000 | $4,995,000 | 7.4% |
| LIVN | June 30, 2025 | 117,040 | $4,597,331 | 73.8% |
| CALC | March 31, 2026 | 683,904 | $4,506,927 | 8.3% |
| VCEL | March 31, 2025 | 80,696 | $4,431,017 | -5.8% |
| SRRK | Sept. 30, 2025 | 125,000 | $4,427,500 | 48.0% |
| CRNX | March 31, 2025 | 85,000 | $4,346,050 | 152.7% |
| ETON | Dec. 31, 2025 | 200,000 | $4,346,000 | 260.3% |
| CBLL | Dec. 31, 2025 | 360,000 | $4,136,400 | 9.2% |
| HROW | Dec. 31, 2025 | 85,498 | $4,119,294 | -14.8% |
| ETON | June 30, 2026 | 166,381 | $4,106,283 | 68.3% |
| TNDM | Sept. 30, 2025 | 200,000 | $3,728,000 | 83.3% |
| SRPT | June 30, 2025 | 58,000 | $3,701,560 | 14.4% |
| WGS | Sept. 30, 2025 | 40,000 | $3,692,400 | -24.5% |
| RCKT | March 31, 2025 | 271,659 | $3,414,754 | -47.1% |
| AKRO | Dec. 31, 2025 | 71,000 | $3,371,080 | No longer tracked |
| MURA | Sept. 30, 2025 | 1,323,877 | $3,269,976 | No longer tracked |
| REPL | March 31, 2025 | 262,500 | $3,178,875 | 50.0% |
| CTMX | Sept. 30, 2025 | 1,304,300 | $2,960,761 | 6.0% |
| OFIX | Sept. 30, 2025 | 261,147 | $2,911,789 | -33.0% |
| ESTA | March 31, 2025 | 59,400 | $2,736,558 | 75.0% |
| IDYA | Dec. 31, 2025 | 100,000 | $2,721,000 | 17.3% |
| DNLI | Sept. 30, 2025 | 182,110 | $2,547,719 | 73.3% |
| XENE | Sept. 30, 2025 | 78,800 | $2,466,440 | 49.9% |
| VKTX | March 31, 2026 | 70,000 | $2,462,600 | 7.0% |
| CBIO | Dec. 31, 2025 | 200,000 | $2,378,000 | 37.4% |
| RAPP | Dec. 31, 2025 | 80,000 | $2,376,000 | 58.6% |
| BLCO | March 31, 2025 | 120,500 | $2,176,230 | 18.8% |
| QDEL | March 31, 2026 | 75,000 | $2,142,000 | -12.4% |
| IOVA | Dec. 31, 2025 | 976,707 | $2,119,454 | 229.1% |
| MRUS | Sept. 30, 2025 | 40,000 | $2,104,000 | No longer tracked |
| MDXH | March 31, 2025 | 851,688 | $2,018,501 | -49.2% |
| ACLX | March 31, 2026 | 30,000 | $1,956,000 | No longer tracked |
| VTGN | Dec. 31, 2025 | 550,000 | $1,952,500 | -62.7% |
| SKIN | Sept. 30, 2025 | 1,000,000 | $1,910,000 | -68.0% |
| ARWR | June 30, 2026 | 28,479 | $1,785,633 | 8.2% |
| OLMA | March 31, 2026 | 69,874 | $1,746,850 | -25.0% |
| ELVN | March 31, 2025 | 75,405 | $1,696,613 | 201.6% |
| BCAX | March 31, 2026 | 100,000 | $1,683,000 | 23.2% |
| KOD | March 31, 2026 | 60,000 | $1,677,600 | 5.2% |
| REGN | March 31, 2025 | 2,300 | $1,638,359 | 32.1% |
| MNKD | Dec. 31, 2025 | 300,000 | $1,611,000 | -24.1% |
| YMAB | Sept. 30, 2025 | 349,982 | $1,578,419 | No longer tracked |
| CTMX | June 30, 2026 | 300,000 | $1,410,000 | -9.9% |
| IMUX | Dec. 31, 2025 | 1,580,007 | $1,392,934 | 2992.7% |
| ADVM | Dec. 31, 2025 | 287,246 | $1,301,224 | No longer tracked |
| LQDA | Dec. 31, 2025 | 50,000 | $1,137,000 | 103.0% |
| WHWK | March 31, 2025 | 333,227 | $1,051,331 | 169.1% |
| EWTX | Sept. 30, 2025 | 76,493 | $1,002,823 | 170.6% |
| ABVX | Sept. 30, 2025 | 125,000 | $956,250 | 40.7% |
| GRAL | March 31, 2026 | 11,000 | $941,490 | 49.1% |
| GUTS | March 31, 2026 | 400,000 | $880,000 | 55.2% |
| VRDN | March 31, 2025 | 45,500 | $872,235 | 82.6% |
| SLNO | Sept. 30, 2025 | 10,000 | $837,800 | No longer tracked |
| EPIX | Dec. 31, 2025 | 4,362,026 | $833,147 | No longer tracked |
| BCYC | Sept. 30, 2025 | 100,000 | $695,000 | -43.7% |
| MYO | Dec. 31, 2025 | 704,275 | $628,213 | No longer tracked |
| MREO | Dec. 31, 2025 | 299,711 | $617,405 | -29.0% |
| APGE | June 30, 2025 | 16,000 | $597,760 | 210.4% |
| TECX | Dec. 31, 2025 | 25,000 | $392,250 | 80.8% |
| COGT | June 30, 2026 | 10,000 | $384,900 | -6.6% |
| TYRA | June 30, 2026 | 10,000 | $383,000 | -17.4% |
| STAA | June 30, 2026 | 20,000 | $374,000 | -19.1% |
| RVMD | Sept. 30, 2025 | 10,000 | $367,900 | 354.7% |
| GSK | March 31, 2025 | 10,110 | $341,920 | 33.6% |
| ANAB | June 30, 2026 | 6,000 | $332,760 | -14.9% |
| RAPP | June 30, 2026 | 10,000 | $312,900 | 15.5% |
| WGS | March 31, 2025 | 4,000 | $307,440 | -8.1% |
| MDGL | March 31, 2026 | 500 | $291,170 | -0.9% |
| IOBT | Sept. 30, 2025 | 192,670 | $267,811 | No longer tracked |
| THC | March 31, 2025 | 2,027 | $255,868 | 104.1% |
| ZYME | June 30, 2026 | 10,000 | $250,400 | 3.5% |
| LBRX | June 30, 2026 | 10,000 | $246,600 | 48.2% |
| ORKA | June 30, 2026 | 5,000 | $245,250 | 12.4% |
| JSPR | June 30, 2026 | 276,312 | $242,105 | 70.0% |
| ONC | March 31, 2025 | 1,150 | $212,417 | 38.2% |
| AXSM | Sept. 30, 2025 | 2,000 | $208,780 | 71.8% |
| ELV | March 31, 2025 | 550 | $202,895 | -8.1% |
| DYN | March 31, 2026 | 10,000 | $195,600 | 45.6% |
| ADPT | Sept. 30, 2025 | 10,000 | $116,500 | 67.6% |
| DCTH | March 31, 2026 | 10,000 | $101,000 | 79.8% |